{"id":1727,"date":"2026-03-30T12:00:56","date_gmt":"2026-03-30T12:00:56","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/03\/30\/lucid-ms-moves-toward-clinical-trial-in-us-that-will-enroll-ms-patients\/"},"modified":"2026-03-30T12:00:56","modified_gmt":"2026-03-30T12:00:56","slug":"lucid-ms-moves-toward-clinical-trial-in-us-that-will-enroll-ms-patients","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/03\/30\/lucid-ms-moves-toward-clinical-trial-in-us-that-will-enroll-ms-patients\/","title":{"rendered":"Lucid-MS moves toward clinical trial in US that will enroll MS patients"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/03\/30\/quantum-soon-seeking-fda-clearance-new-trial-testing-lucid-ms-patients\/\" title=\"Lucid-MS moves toward clinical trial in US that will enroll MS patients\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"533\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2026\/03\/iStock-2054515405-800x533.jpg\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"Icons showing check marks are superimposed over an image of a person&#039;s hands typing on a laptop keyboard.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"160803\" \/><\/a><\/p>\n<p>Quantum Biopharma is preparing to seek permission in the U.S. to launch its planned clinical trial of Lucid-MS, an oral therapy that aims to slow myelin loss \u2014 which ultimately results in the neurological problems that drive multiple sclerosis (MS) \u2014 in people with the progressive disease. The company said it expects to submit an [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/03\/30\/quantum-soon-seeking-fda-clearance-new-trial-testing-lucid-ms-patients\/\">Lucid-MS moves toward clinical trial in US that will enroll MS patients<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/03\/30\/quantum-soon-seeking-fda-clearance-new-trial-testing-lucid-ms-patients\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Quantum Biopharma is preparing to seek permission in the U.S. to launch its planned clinical trial of Lucid-MS, an oral therapy that aims to slow myelin loss \u2014 which ultimately results in the neurological problems that drive multiple sclerosis (MS) \u2014 in people with the&hellip;<\/p>\n","protected":false},"author":0,"featured_media":1728,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-1727","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=1727"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1727\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/1728"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=1727"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=1727"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=1727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}